Tian et al. (2019) observed an increase in the expression of miR-31 in the inflamed mucosa in patients with IBD (inflammatory bowel disease) and mice with DSS-induced colitis, where the NF-κB and STAT3 signaling pathways are involved [41]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.